Cost-effectiveness of gestational diabetes screening in middle-income countries: a systematic review

Pariqa Annisa; Deliana Br Karo; Asti Ratnaningrum; Yohana Samosir; Andari Wuri Astuti; Ajeng Viska Icanervilia; Maria Fatima De Moniz

doi:10.31101/jkk.3636

Authors

Pariqa Annisa Universitas Aisyiyah Yogyakarta, Indonesia
Deliana Br Karo Universitas Aisyiyah Yogyakarta, Indonesia
Asti Ratnaningrum Universitas Aisyiyah Yogyakarta, Indonesia
Yohana Samosir Universitas Aisyiyah Yogyakarta, Indonesia
Andari Wuri Astuti Universitas Aisyiyah Yogyakarta, Indonesia
Ajeng Viska Icanervilia University of Groningen, Netherlands
Maria Fatima De Moniz Servisu Municipal Da Saude Covalima, Timor-Leste

DOI:

https://doi.org/10.31101/jkk.3636

Keywords:

Cost-effectiveness analysis; economic evaluation; gestational diabetes mellitus; GDM screening; middle-income countries

Abstract

The majority of GDM occurs in low- and middle-income countries. GDM is associated with increased maternal and infant complications as well as an increased burden of health financing. Accurate and cost-effective screening is needed for prevention and further treatment. Unfortunately, there is a lack of research on the cost-effectiveness of GDM screening in middle-income countries. The objective of this study was to uncover scientific proof concerning the cost-effectiveness analysis of screening for gestational diabetes in middle-income countries. We conducted a systematic review using Pubmed and ScienceDirect. Four reviewers screened the title and abstract of each article, followed by the selection of the full text based on the inclusion criteria (cost-effectiveness analysis studies of GDM screening and original research). Quality articles were assessed using the CHEC-Extended tool. A total search of 1239 articles found 3 studies that met the inclusion criteria. A screening program is more cost-effective than no screening, this represents a savings of $1,329,671. The ICER value is less than 3x GDP per capita, which indicates that the intervention is cost-effective. Compared to two-step screening, one-step screening is more likely to be cost-effective since it detects more cases. As the prevention of DALYs is mainly due to the prevention of T2DM, middle-income countries should focus more on postnatal care for women with GDM in the future. It is advised that long-term follow-up studies be a major focus of future research in order to evaluate the follow-up GDM screening intervention's possible long-term health benefits and financial effects.

Author Biography

Andari Wuri Astuti, Universitas Aisyiyah Yogyakarta

Google Scholar URL Scopus ID 57211968612

References

Akinyemi, O. A., Weldeslase, T. A., Odusanya, E., Akueme, N. T., Omokhodion, O. V., Fasokun, M. E., Makanjuola, D., Fakorede, M., & Ogundipe, T. (2023). Profiles and Outcomes of Women with Gestational Diabetes Mellitus in the United States. Cureus, 15(7), e41360. https://doi.org/10.7759/cureus.41360

American Diabetes Association. (2019). 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020. Diabetes Care, 43(Supplement_1), S14–S31. https://doi.org/10.2337/dc20-S002

Bai, W., Wang, H., Fang, R., Lin, M., Qin, Y., Han, H., Cui, J., Zhang, R., Ma, Y., Chen, D., Zhang, W., Wang, L., & Yu, H. (2023). Evaluating the effect of gestational diabetes mellitus on macrosomia based on the characteristics of oral glucose tolerance test. Clinica Chimica Acta, 544, 117362. https://doi.org/10.1016/j.cca.2023.117362

Behboudi-Gandevani, S., Amiri, M., Bidhendi Yarandi, R., & Ramezani Tehrani, F. (2019). The impact of diagnostic criteria for gestational diabetes on its prevalence: A systematic review and meta-analysis. Diabetology & Metabolic Syndrome, 11(1), 11. https://doi.org/10.1186/s13098-019-0406-1

Bhandiwad, A., Divyasree, B., & Gowda, S. L. (2015). Adverse maternal and perinatal outcomes in gestational diabetes mellitus. International Journal of Medical Research & Health Sciences, 4(4), 775. https://doi.org/10.5958/2319-5886.2015.00152.6

Celen, S., Yildiz, Y., Kahyaoglu, S., Kaymak, O., Ozel, M., Timur, H., & Danisman, N. (2012). Cost-Effectivity Analysis of One-Step Versus Two-Step Screening for Gestational Diabetes. The Eurasian Journal of Medicine, 44(2), 84–87. https://doi.org/10.5152/eajm.2012.20

Cho, N. H., Shaw, J. E., Karuranga, S., Huang, Y., da Rocha Fernandes, J. D., Ohlrogge, A. W., & Malanda, B. (2018). IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Research and Clinical Practice, 138, 271–281. https://doi.org/10.1016/j.diabres.2018.02.023

Daroudi, R., Akbari Sari, A., Nahvijou, A., & Faramarzi, A. (2021). Cost per DALY averted in low, middle- and high-income countries: Evidence from the global burden of disease study to estimate the cost-effectiveness thresholds. Cost Effectiveness and Resource Allocation, 19(1), 7. https://doi.org/10.1186/s12962-021-00260-0

Eades, C. E., Styles, M., Leese, G. P., Cheyne, H., & Evans, J. M. (2015). Progression from gestational diabetes to type 2 diabetes in one region of Scotland: An observational follow-up study. BMC Pregnancy and Childbirth, 15(1), 1–6. https://doi.org/10.1186/s12884-015-0457-8

Haque, M. M., Tannous, W. K., Herman, W. H., Immanuel, J., Hague, W. M., Teede, H., Enticott, J., Cheung, N. W., Hibbert, E., Nolan, C. J., Peek, M. J., Wong, V. W., Flack, J. R., Mclean, M., Sweeting, A., Gianatti, E., Kautzky-Willer, A., Harreiter, J., Mohan, V., … Simmons, D. (2024). Cost-effectiveness of diagnosis and treatment of early gestational diabetes mellitus: Economic

evaluation of the TOBOGM study, an international multicenter randomized controlled trial. EClinicalMedicine, 71. https://doi.org/10.1016/j.eclinm.2024.102610

He, Z., Tang, Y., Xie, H., Lin, Y., Liang, S., Xu, Y., Chen, Z., Wu, L., Sheng, J., Bi, X., Pang, M., Akinwunmi, B., Xiao, X., & Ming, W. (2020). Economic burden of IADPSG gestational diabetes diagnostic criteria in China: Propensity score matching analysis from a 7-year retrospective cohort. BMJ Open Diabetes Research & Care, 8(1), e001538. https://doi.org/10.1136/bmjdrc-2020-001538

Herath, H., Herath, R., & Wickremasinghe, R. (2017). Gestational diabetes mellitus and risk of type 2 diabetes 10 years after the index pregnancy in Sri Lankan women—A community based retrospective cohort study. PLOS ONE, 12(6), e0179647. https://doi.org/10.1371/journal.pone.0179647

Jafari-Shobeiri, M., Ghojazadeh, M., Azami-Aghdash, S., Naghavi-Behzad, M., Piri, R., Pourali-Akbar, Y., Nasrollah-Zadeh, R., Bayat-Khajeh, P., & Mohammadi, M. (2015). Prevalence and Risk Factors of Gestational Diabetes in Iran: A Systematic Review and Meta-Analysis. Iranian Journal of Public Health, 44(8), 1036–1044.

Lee, J., Ouh, Y., Ahn, K. H., Hong, S. C., Oh, M.-J., Kim, H.-J., & Cho, G. J. (2017). Preeclampsia: A risk factor for gestational diabetes mellitus in subsequent pregnancy. PLoS ONE, 12(5), e0178150. https://doi.org/10.1371/journal.pone.0178150

Leech, A. A., Kim, D. D., Cohen, J. T., & Neumann, P. J. (2018). Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries: Trends in Cost-per-DALY Studies. Value in Health, 21(7), 759–761. https://doi.org/10.1016/j.jval.2017.12.016

Li-zhen, L., Yun, X., Xiao-Dong, Z., Shu-bin, H., Zi-lian, W., Adrian Sandra, D., & Bin, L. (2019). Evaluation of guidelines on the screening and diagnosis of gestational diabetes mellitus: Systematic review. BMJ Open, 9(5), e023014. https://doi.org/10.1136/bmjopen-2018-023014

Marseille, E., Lohse, N., Jiwani, A., Hod, M., Seshiah, V., Yajnik, C. S., Arora, G. P., Balaji, V., Henriksen, O., Lieberman, N., Chen, R., Damm, P., Metzger, B. E., & Kahn, J. G. (2013). The cost-effectiveness of gestational diabetes screening including prevention of type 2 diabetes: Application of a new model in India and Israel. The Journal of Maternal-Fetal & Neonatal Medicine: The Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 26(8), 802–810. https://doi.org/10.3109/14767058.2013.765845

Meregaglia, M., Dainelli, L., Banks, H., Benedetto, C., Detzel, P., & Fattore, G. (2018). The short-term economic burden of gestational diabetes mellitus in Italy. BMC Pregnancy and Childbirth, 18(1), 58. https://doi.org/10.1186/s12884-018-1689-1

Mo, X., Gai Tobe, R., Takahashi, Y., Arata, N., Liabsuetrakul, T., Nakayama, T., & Mori, R. (2021). Economic Evaluations of Gestational Diabetes Mellitus Screening: A Systematic Review. Journal of Epidemiology, 31(3), 220–230. https://doi.org/10.2188/jea.JE20190338

Mohan, V., Mahalakshmi, M. M., Bhavadharini, B., Maheswari, K., Kalaiyarasi, G., Anjana, R. M., Uma, R., Usha, S., Deepa, M., Unnikrishnan, R., Pastakia, S. D., Malanda, B., Belton, A., & Kayal, A. (2014). Comparison of screening for gestational diabetes mellitus by oral glucose tolerance tests done in the non-fasting (random) and fasting states. Acta Diabetologica, 51(6), 1007–1013. https://doi.org/10.1007/s00592-014-0660-5

Neumann, P. J., Thorat, T., Zhong, Y., Anderson, J., Farquhar, M., Salem, M., Sandberg, E., Saret, C. J., Wilkinson, C., & Cohen, J. T. (2016). A Systematic Review of Cost-Effectiveness Studies Reporting Cost-per-DALY Averted. PLOS ONE, 11(12), e0168512. https://doi.org/10.1371/journal.pone.0168512

Ochalek, J. M., Lomas, J., & Claxton, K. P. (2015). Cost per DALY averted thresholds for low- and middle-income countries: Evidence from cross country data. Cost per DALY Averted Thresholds for Low- and Middle-Income Countries, 1–50.

Odnoletkova, I., Goderis, G., Pil, L., Nobels, F., Aertgeerts, B., Annemans, L., & Ramaekers, D. (2014). Cost-effectiveness of therapeutic education to prevent the development and progression of type 2 diabetes. Systematic review. Journal of Diabetes & Metabolism, 05. https://doi.org/10.4172/2155-6156.1000438

Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., … Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, n71. https://doi.org/10.1136/bmj.n71

Ramezani Tehrani, F., Rahmati, M., Farzadfar, F., Abedini, M., Farahmand, M., Hosseinpanah, F., Hadaegh, F., Torkestani, F., Valizadeh, M., Azizi, F., & Behboudi-Gandevani, S. (2023). One-step versus two-step screening for diagnosis of gestational diabetes mellitus in Iranian population: A randomized community trial. Frontiers in Endocrinology, 13. https://doi.org/10.3389/fendo.2022.1039643

Rani, P. R., & Begum, J. (2016). Screening and Diagnosis of Gestational Diabetes Mellitus, Where Do We Stand. Journal of Clinical and Diagnostic Research : JCDR, 10(4), QE01–QE04. https://doi.org/10.7860/JCDR/2016/17588.7689

Saccone, G., Caissutti, C., Khalifeh, A., Meltzer, S., Scifres, C., Simhan, H. N., Kelekci, S., Sevket, O., & Berghella, V. (2019). One step versus two step approach for gestational diabetes screening: Systematic review and meta-analysis of the randomized trials. The Journal of Maternal-Fetal & Neonatal Medicine: The Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 32(9), 1547–1555. https://doi.org/10.1080/14767058.2017.1408068

Saeedi, M., Cao, Y., Fadl, H., Gustafson, H., & Simmons, D. (2021). Increasing prevalence of gestational diabetes mellitus when implementing the IADPSG criteria: A systematic review and meta-analysis. Diabetes Research and Clinical Practice, 172. https://doi.org/10.1016/j.diabres.2020.108642

Sweeting, A., Wong, J., Murphy, H. R., & Ross, G. P. (2022). A Clinical Update on Gestational Diabetes Mellitus. Endocrine Reviews, 43(5), 763–793. https://doi.org/10.1210/endrev/bnac003

Utz, B., & De Brouwere, V. (2016). “Why screen if we cannot follow-up and manage?” Challenges for gestational diabetes screening and management in low and lower-middle income countries: Results of a cross-sectional survey. BMC Pregnancy and Childbirth, 16(1), 341. https://doi.org/10.1186/s12884-016-1143-1

van Delft, L. C. J., Kelleners-Smeets, N. W. J., Peeters, A., Mosterd, K., & Essers, B. A. B. (2023). A systematic review of economic evaluations for the interventions of superficial basal cell carcinoma. EJC Skin Cancer, 1, 100008. https://doi.org/10.1016/j.ejcskn.2023.100008

Wang, H., Li, N., Chivese, T., Werfalli, M., Sun, H., Yuen, L., Hoegfeldt, C. A., Elise Powe, C., Immanuel, J., Karuranga, S., Divakar, H., Levitt, Na., Li, C., Simmons, D., Yang, X., & IDF Diabetes Atlas Committee Hyperglycaemia in Pregnancy Special Interest Group. (2022). IDF Diabetes Atlas: Estimation of Global and Regional Gestational Diabetes Mellitus Prevalence for 2021 by International Association of Diabetes in Pregnancy Study Group’s Criteria. Diabetes Research and Clinical Practice, 183, 109050. https://doi.org/10.1016/j.diabres.2021.109050

Wang, Y.-Y., Liu, Y., Li, C., Lin, J., Liu, X.-M., Sheng, J.-Z., & Huang, H.-F. (2019). Frequency and risk factors for recurrent gestational diabetes mellitus in primiparous women: A case control study. BMC Endocrine Disorders, 19(1), 22. https://doi.org/10.1186/s12902-019-0349-4

WHO. (2024, April 26). Maternal mortality. https://www.who.int/news-room/fact-sheets/detail/maternal-mortality

World Bank. (2016). GDP per capita (current US$)—India. World Bank Open Data. https://data.worldbank.org

Yang, Y., & Wu, N. (2022). Gestational Diabetes Mellitus and Preeclampsia: Correlation and Influencing Factors. Frontiers in Cardiovascular Medicine, 9, 831297. https://doi.org/10.3389/fcvm.2022.831297

Ye, W., Luo, C., Huang, J., Li, C., Liu, Z., & Liu, F. (2022). Gestational diabetes mellitus and adverse pregnancy outcomes: Systematic review and meta-analysis. BMJ, 377, e067946. https://doi.org/10.1136/bmj-2021-067946

Zhang, L., Chen, W., Wang, Y., Ma, R., Du, M., & Xu, X. (2015). Cost-Effectiveness Analysis of Gestational Diabetes Mellitus Screening in Urban Chinese Setting. Value in Health, 18(7), A607–A608. https://doi.org/10.1016/j.jval.2015.09.2099

Zhuang, W., Lv, J., Liang, Q., Chen, W., Zhang, S., & Sun, X. (2020). Adverse effects of gestational diabetes-related risk factors on pregnancy outcomes and intervention measures. Experimental and Therapeutic Medicine, 20(4), 3361–3367. https://doi.org/10.3892/etm.2020.9050